This report analyzes the disruptive themes that have driven M&A activity in Q2 2022 in the Medical Devices Sector
There was just a marginal increase in deal value recorded in Q2 2022 of $16 billion from $ 13 billion in Q1 2022, but deal volume decreased by 7% compared to the previous quarter
There was just a marginal increase in deal value recorded in Q2 2022 of $16 billion from $ 13 billion in Q1 2022, but deal volume decreased by 7% compared to the previous quarter
Scope
- This report provides an overview of merger and acquisition activity globally in Q2 2022 in Medical Devices Sector
- It identifies the themes driving most notable to deals announced in Q2 2022 in the Medical Devices Sector
Reasons to Buy
- Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
- In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Executive Summary
- Review of global medical devices M&A deals in Q2 2022
- Themes driving global medical devices M&A deals in Q2 2022
- Appendix 1: Deal selection criteria
- Appendix 2: Thematic Research Methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Evolent Health
- Trajan Scientific and Medical
- Boston Scientific
- ResMed
- OrthoPediatrics
- Guardant Health
- Azenta
- Becton Dickinson
- EW Healthcare
- Rubberex
- DeNA
- Lakeshore Acquisition
- Cochlear
- Medtronic
- Wallaby Medical
- Seastar Medical
- Bloomage Biotechnology
- ArchiMed
- Halozyme Therapeutics
- Castle Biosciences
- Implantable Provider Group
- Chromatography Research Supplies
- M.I.Tech
- MediFox DAN
- Pega Medical
- Guardant Health AMEA
- Barkey
- Parata Systems
- TherapeuticsMD
- Reszon Diagnostics International
- Allm
- Prosomnus
- Oticon Medical
- Acutus Medical
- Phenox
- LMF Acquisition Opportunities
- Beijing Yierkang Biological Engineering
- Natus Medical
- Antares Pharma
- AltheaDx
